Medical Blog About Treatment Abroad

Esophageal cancer is one of the twenty most widespread cancer types. The disease can develop at any age, but most often it is diagnosed over the age of 60, when treatment options are already somewhat limited by the patient's chronic conditions. Patients who undergo treatment in Germany have a chance to significantly increase...

Dendritic cell prostate cancer treatment represents a groundbreaking immunotherapy approach, recognized by the 2011 Nobel Prize in Physiology or Medicine, awarded to Ralph Steinman. This innovative method can be prescribed to men of all ages and at any stage of prostate cancer, serving as an effective addition to standard treatment....

Thyroid cancer is one of the most rapidly growing endocrine malignancies worldwide. In Europe, the annual incidence reaches 8.3 cases per 100,000 population, while the mortality remains relatively low at 0.33 per 100,000. This situation reflects the effectiveness of modern diagnostic tools and treatment options, as well as the generally...

Cervical cancer affects approximately 660,000 women worldwide each year, making it the fourth most common cancer among women globally. While early detection typically offers excellent cure rates, advanced cases require innovative treatment approaches. Dendritic cell therapy represents a promising personalized immunotherapy...

Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disease that primarily targets synovial joints, leading to inflammation, swelling, pain, and eventual joint deformity if left untreated. It affects about 0.5% to 1% of the global population, with women being two to three times more likely to develop the disease than men.

Cervical cancer is among the most widespread gynecological cancers worldwide, with outcomes that vary greatly depending on region and healthcare access. The World Health Organization reports that more than 600,000 women are diagnosed annually, and almost 340,000 lose their lives to the disease, even though it can often be...

According to MDPI clinical data, melanoma accounts for 1.7% of global cancer diagnoses and is the fifth most common cancer in the US. Melanoma incidence is rising in developed, predominantly fair-skinned countries, growing over 320% in the US since 1975. That is why it is very important to look for new effective treatments, one of...

With 2.5 million new cases in 2022 and 1.8 million deaths, lung cancer remains the most common cancer diagnosed worldwide. The challenge is early detection: only 17% and 15% of lung cancers in women and men, respectively, are diagnosed at stage 1, when survival is 80-93%. Those with advanced lung cancer have survival rates of less than 20%.